<DOC>
	<DOCNO>NCT01277848</DOCNO>
	<brief_summary>The PLAC1 gene recently describe X-linked gene map region X chromosome think important normal fetal placental development . Elevated level PLAC1 mRNA detect preeclampsia appear directly relate disease severity . PLAC1 may serve useful marker placental dysfunction threaten pregnancy . The objective study measure prevalence circulate anti-PLAC1 antibody pregnant maternal serum correlate pregnancy outcome . It likely woman antibodies high risk adverse pregnancy outcome . Approximately 5 % ( 50 1000 ) expect anti-PLAC1 antibody base previously report data . The prevalence antibodies clinical impact pregnancy outcomes determine . 1000 healthy , multiparous primigravid woman screen anti-PLAC1 antibody routine prenatal clinic visit . Subjects enrol first clinic visit USF Health , South Tampa Center , Department Obstetrics . Blood ( 1.0 ml ) obtain part routine blood draw time enrollment . Blood collect drawn part routine laboratory test determine primary care provider . Additional blood sample ( 1.0 ml ) collect throughout pregnancy time blood obtain routine otherwise clinically indicated laboratory test . A maximum 5 sample collect pregnancy . Maternal demographic data collect patient follow longitudinally completion pregnancy ascertain clinical status pregnancy , onset premature labor , premature rupture membrane , delivery date , gestational age delivery .</brief_summary>
	<brief_title>PLAC1 Reproduction</brief_title>
	<detailed_description />
	<criteria>Pregnant , primigravid multigravid woman age 14 55 , receive prenatal care USF Health , STC , Dept . Obstetrics . presence significant cardiac disease renal disease chronic hypertension chromosomal abnormality cancer</criteria>
	<gender>Female</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>PLAC1</keyword>
	<keyword>pregnant</keyword>
	<keyword>first prenatal visit</keyword>
	<keyword>pre-eclampsia</keyword>
</DOC>